Han Xiao

发表

The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC

B. Li, Jingxian Shen, Bin Li, 2020, European Radiology.

Prediction of microvascular invasion in hepatocellular carcinoma with expert‐inspiration and skeleton sharing deep learning

Yuchen Guo, Qian Zhou, Jingxian Shen, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Deep learning for evaluation of microvascular invasion in hepatocellular carcinoma from tumor areas of histology images

W. Wang, B. Liao, Bin Li, 2022, Hepatology International.

The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion

Yaojun Zhang, Bin Li, Shuling Chen, 2022, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.

Minshan Chen, Qian Zhou, Shuling Chen, 2019, Radiology.

The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas

Jun Yu, Minghui He, Lixia Xu, 2020, Clinical Cancer Research.

Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study

Q. Lv, Qian Zhou, S. Peng, 2020, BMJ open diabetes research & care.

Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population

Lixia Xu, Jingxian Shen, S. Feng, 2022, BMC cancer.

Combinatory local ablation and immunotherapies for hepatocellular carcinoma: Rationale, efficacy, and perspective

Shuling Chen, S. Peng, Zhenwei Peng, 2022, Frontiers in Immunology.

Impact of Time-To-Surgery on the Prognosis of Patients with T1 Renal Cell Carcinoma: Implications for the COVID-19 Pandemic

Bin Li, Han Xiao, S. Peng, 2022, Journal of clinical medicine.

Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study

F. Hou, Yang Yang, K. Cheng, 2020, BMJ.

Combination neoantigen-based dendritic cell vaccination and adoptive T-cell transfer induces antitumor responses against recurrence of hepatocellular carcinoma.

Longqing Tang, W. Wang, Minghui He, 2022, Cancer immunology research.

Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery

Xiao-yan Xie, B. Peng, Shuling Chen, 2018, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging

D. Gu, Jie Tian, Xin Li, 2019, European Radiology.

Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model

Ning Zhang, Heping Li, S. Peng, 2018, BMC Cancer.

METTL1-mediated m7G tRNA modification promotes lenvatinib resistance in hepatocellular carcinoma.

Lixia Xu, Shuibin Lin, Yi Zhao, 2022, Cancer research.

A Pre-Operative Prognostic Score for Patients With Advanced Hepatocellular Carcinoma Who Underwent Resection

Xin Li, Qian Zhou, S. Feng, 2021, Frontiers in Oncology.

Targeting N7-Methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.

Lixia Xu, Shuling Chen, S. Peng, 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

Development and external validation of a prognosis model to predict outcomes after curative resection of early-stage intrahepatic cholangiocarcinoma

Bin Li, Han Xiao, Jingxian Shen, 2023, Frontiers in Surgery.